Optimizing Micronization and Spray-Drying to Achieve High Yields from Clinical to Commercial
Summary: The pharmaceutical industry faces mounting pressure to deliver consistent, high-quality products whilst managing escalating costs and regulatory demands. From API development through to commercial supply, particle engineering, particularly micronization and spray-drying, have become cornerstone technologies for addressing these challenges.
As drug formulations become more complex, maintaining precise and repeatable particle size control is key – not just for drug performance, but also for reliable, large-scale manufacturing. The decision to use one technique over the other depends on a range of factors, including the molecule’s characteristics, regulatory requirements, and scalability considerations.